Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New HIV vaccine from VaxGen cleared for phase I/II studies

Jan. 20, 1998

Provir set to enter final stage of development for AIDS-related diarrhea

Jan. 19, 1998

Peptide HIV protease inhibitors claimed by Merck & Co.

Jan. 19, 1998

Anti-HIV therapy with adefovir may also prevent the development of Kaposi's sarcoma

Jan. 16, 1998

Further mechanism of action studies described for AMD-3100

Jan. 16, 1998

Unimed submits NDA for AIDS-related illness

Jan. 16, 1998

Novel AIDS Rx technology available for licensing from NIH

Jan. 16, 1998

Three new AIDS vaccine trials examine novel approaches

Jan. 15, 1998

HIV RT inhibitors available for licensing from NIH

Jan. 15, 1998

Progenics, Roche collaborate on next-generation anti-HIV agents

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...